Two receptor pathways
Tirzepatide is a synthetic, acylated peptide with agonist activity at both the GIP and GLP-1 receptors. This dual receptor identity is the item's distinguishing molecular feature.
Comparative ligand research
The 10 mg presentation supports clear documentation in comparative receptor binding, cellular signalling analysis and analytical studies of modified peptide ligands.
Scientific mechanism
Tirzepatide is an acylated peptide with agonist activity at both the GIP and GLP-1 receptors. In receptor research, the two ligand–receptor interactions and their measured cAMP signals are characterised individually and comparatively.
Batch documentation
Before each study, always check the product label, selected presentation and batch number. Compare these details, where available, with the batch documentation and lab results.
Important research-use notice
This item is intended exclusively for controlled analytical and in-vitro laboratory research. It is not intended for human or animal consumption, use, administration, diagnosis, prevention or treatment. VLT Labs does not provide dosage, medical, health or application advice.
